Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Pancreatic Cancer
Clinical trial register · Italy

Pancreatic Cancer Trials in Italy, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6788 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:19 UTC
6788
Studies in scope
all four open statuses
4077
Recruiting now
open to new participants
1016
Lead sponsors
across recruiting studies
Top sites
Milan 12 Padova 7 Naples 4 Pisa 4 Roma 3

Pancreatic Cancer trials in Italy

17 of 6788 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Inna Chen, MD
Not applicable
250
Padova
2026-11-01
Not yet open
Endoscopic Management of Biliopancreatic Disease in the Lombardy Pancreas Units
NCT07418164Pancreatic Cancer, Biliopancreatic Diseases, Periampullary Neoplasms
IRCCS San Raffaele
Observational
2,500
Bergamo, Brescia, Cremona, Legnano, Mantua, Milan, Monza, Pavia
2026-10-31
Recruiting
Revolution Medicines, Inc.
Phase 3
670
Florence, Padova
2026-05-22
Recruiting
Alpha Radiation Emitters for the Treatment of Pancreatic Cancer for the Treatment of Locally Advanced Pancreatic Cancer
NCT06026943Pancreatic Cancer, Unresectable Pancreatic Cancer, Pancreatic Adenocarcinoma
Alpha Tau Medical LTD.
Not applicable
15
Verona
2026-05-06
Not yet open
PAN-CLO-BU (PANcreas-CLOstridium-BUtyricum)
NCT07422103Pancreatic Cancer, Pancreatic Diseases, Gastrointestinal Symptoms, Clostridium Butyricum Miyairi
Casa di Cura Dott. Pederzoli
Not applicable
158
Peschiera del Garda
2026-03-15
Recruiting
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
NCT07491445Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.
Phase 3
900
Milan, Padova, Roma, Tricase, Verona
2026-03-09
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
NCT07252232Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal Adenocarcinoma (PDAC)
Revolution Medicines, Inc.
Phase 3
500
Milan, Naples, Padova, Pisa, Verona
2025-12-15
Active, closed
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreatic Cancer
DrugM9140
EMD Serono Research & Development Institute, Inc.
Phase 1/2
184
Rome, Ancona, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2025-01-29
Active, closed
Revolution Medicines, Inc.
Phase 3
500
Milan, Padova, Pisa
2024-10-16
Recruiting
Management of Malignant Gastric Outlet Obstruction Between Surgery and Endoscopy
NCT06071507Gastric Outlet Obstruction, Pancreatic Cancer
IRCCS San Raffaele
Observational
250
Milan, Palermo
2024-04-15
Active, closed
Prehabilitation in Pancreatic Surgery
NCT06069297Pancreatic Cancer, Periampullary Cancer, Frailty Syndrome, Malnutrition
IRCCS San Raffaele
Not applicable
238
Milan
2023-07-14
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna
2022-05-22
Recruiting
Radiology Registry on Pancreatic Malignancies
NCT05714111Pancreatic Cancer, Pancreas Neoplasm, Pancreas Disease, Pancreas Cyst
IRCCS San Raffaele
Observational
1,300
Milan
2022-03-04
Recruiting
Pancreatic Cancer Evolution Upon Treatment
NCT05195281Pancreatic Cancer
IRCCS San Raffaele
Not applicable
80
Milan
2021-07-14
Active, closed
AstraZeneca
Phase 1/2
702
Milan, Modena, Naples, Padova, Roma
2020-11-12
Recruiting
BOLD-100 in Combination With FOLFOX With or Without Bevacizumab for the Treatment of Advanced, Solid Tumours
NCT04421820Colorectal Cancer, Pancreatic Cancer, Gastric Cancers, Cholangiocarcinoma
Bold Therapeutics, Inc.
Phase 1/2
220
Milan, Naples, Pisa
2020-08-28
Active, closed
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer
NCT03816163Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 2
393
Rozzano, Candiolo, Cremona, Lombardia, Milan, Toscana, Veneto
2019-03-15
Rows per page Showing 1–17 of 17
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-italy/condition/pancreatic-cancer

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,788 studies in total at the last sync on 13 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 17 of those studies listing the condition Pancreatic Cancer.

How many Pancreatic Cancer trials are recruiting in Italy?

9 of the 17 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:19 UTC sync. A further 3 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Pancreatic Cancer), 17 studies
PhaseStudiesRecruitingShare
Not applicable5229.4%
Observational4323.5%
Phase 34323.5%
Phase 1/23117.6%
Phase 2105.9%

Most active sponsors

Lead sponsors with the most studies (Pancreatic Cancer)
Lead sponsorStudiesRecruiting
IRCCS San Raffaele53
Revolution Medicines, Inc.43
Alpha Tau Medical LTD.11
Astellas Pharma Global Development, Inc.10
AstraZeneca10
Bold Therapeutics, Inc.11
Casa di Cura Dott. Pederzoli10
EMD Serono Research & Development Institute, Inc.10
Inna Chen, MD10
IRCCS Azienda Ospedaliero-Universitaria di Bologna11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.